UOC

UBS O'Connor Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.75%
This Quarter Est. Return
1 Year Est. Return
+38.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.3B
AUM Growth
-$463M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
460
New
Increased
Reduced
Closed

Top Buys

1
+$405M
2
+$209M
3
+$195M
4
HEES
H&E Equipment Services
HEES
+$103M
5
JWN
Nordstrom
JWN
+$96.6M

Top Sells

1
+$305M
2
+$235M
3
+$216M
4
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
5
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M

Sector Composition

1 Energy 21.95%
2 Financials 16.62%
3 Healthcare 15.59%
4 Technology 13.54%
5 Industrials 12.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLCO icon
201
Melco Resorts & Entertainment
MLCO
$3.15B
$405K 0.01%
+76,800
LRMR icon
202
Larimar Therapeutics
LRMR
$325M
$387K 0.01%
180,027
-8,516
BMRN icon
203
BioMarin Pharmaceuticals
BMRN
$10.1B
$372K 0.01%
5,258
-21,582
GRAB icon
204
Grab
GRAB
$23.7B
$318K 0.01%
+70,291
TRML
205
DELISTED
Tourmaline Bio
TRML
$272K 0.01%
+17,860
ORIC icon
206
Oric Pharmaceuticals
ORIC
$1.19B
$266K 0.01%
47,642
-127,204
LION icon
207
Lionsgate Studios
LION
$1.84B
$261K 0.01%
35,000
-95,774
CGEM icon
208
Cullinan Oncology
CGEM
$437M
$249K 0.01%
32,903
-23,192
DYN icon
209
Dyne Therapeutics
DYN
$3.06B
$224K 0.01%
21,422
+8,838
DRUG
210
Bright Minds Biosciences
DRUG
$364M
$215K 0.01%
+5,963
EH
211
EHang Holdings
EH
$1.22B
$209K 0.01%
+10,000
ARQT icon
212
Arcutis Biotherapeutics
ARQT
$2.94B
$206K 0.01%
13,201
-64,354
CATX icon
213
Perspective Therapeutics
CATX
$173M
$205K 0.01%
96,060
-27,183
ABBV icon
214
AbbVie
ABBV
$381B
$204K 0.01%
973
-6,515
SLN
215
Silence Therapeutics
SLN
$307M
$177K 0.01%
62,639
-66,351
CNTB
216
Connect Biopharma Holdings
CNTB
$93.6M
$148K ﹤0.01%
268,946
-241,755
AMC icon
217
AMC Entertainment Holdings
AMC
$1.29B
$114K ﹤0.01%
39,688
-36,306
ERAS icon
218
Erasca
ERAS
$655M
$104K ﹤0.01%
75,627
-153,973
KPTI icon
219
Karyopharm Therapeutics
KPTI
$96.3M
$88.4K ﹤0.01%
23,640
-75,275
EVLVW icon
220
Evolv Technologies Warrant
EVLVW
$7.06M
$77K ﹤0.01%
463,341
VYNE icon
221
VYNE Therapeutics
VYNE
$8.34M
$72K ﹤0.01%
45,557
-200,243
CLBR.WS
222
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$69.3K ﹤0.01%
90,000
-10,000
CRVS icon
223
Corvus Pharmaceuticals
CRVS
$569M
$66.3K ﹤0.01%
20,850
-19,150
CCCC icon
224
C4 Therapeutics
CCCC
$210M
$63.8K ﹤0.01%
39,868
-97,492
XFOR icon
225
X4 Pharmaceuticals
XFOR
$314M
$59.6K ﹤0.01%
8,420
-33,725
7 8
9
10 11